Evoke Pharma, Inc. (EVOK)
USD 3.09
(6.19%)
USD 3.09
(6.19%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -4.98 Million | -6.59 Million | -12.35 Million | -6.63 Million | -5.76 Million | -6.97 Million |
| Net Income | -7.79 Million | -8.22 Million | -8.53 Million | -13.15 Million | -7.12 Million | -7.56 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 1.12 Million | 1.45 Million | 1.87 Million | 1.62 Million | 1.37 Million | 1.53 Million |
| Change in working capital | 1.55 Million | 132.4 Thousand | -5.61 Million | 4.89 Million | -10.39 Thousand | -518.55 Thousand |
| Other non-cash items | 129.07 Thousand | 37.02 Thousand | -75.13 Thousand | 1.44 Million | 1.37 Million | -433.39 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | -3.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -119.29 Thousand | 7.29 Million | 13.42 Million | 9.03 Million | 6.1 Million | 4.61 Million |
| Debt repayment | - | -37.02 Thousand | - | -5.1 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | 119.41 Thousand | - | - |
| Common Stock Issuance | -119.29 Thousand | 7.44 Million | 13.42 Million | 3.59 Million | 6.1 Million | 4.61 Million |
| Other Financing Activities | -119.29 Thousand | -111.96 Thousand | 13.42 Million | 15.52 Million | 6.1 Million | 4.61 Million |
| Accounts receivables | -48.23 Thousand | -329.63 Thousand | -271.88 Thousand | 4.6 Million | - | - |
| Accounts payables | 655.12 Thousand | 60.28 Thousand | -527.85 Thousand | 416.42 Thousand | 106.28 Thousand | -440.38 Thousand |
| Inventory | -192.46 Thousand | -103.84 Thousand | 20.94 Thousand | -236.48 Thousand | - | - |
| Other working capital | 1.13 Million | 505.6 Thousand | -4.84 Million | 112.99 Thousand | -116.67 Thousand | -78.17 Thousand |
| Cash at beginning of period | 9.84 Million | 9.14 Million | 8.06 Million | 5.66 Million | 5.31 Million | 7.67 Million |
| Cash at end of period | 4.73 Million | 9.84 Million | 9.14 Million | 8.06 Million | 5.66 Million | 5.31 Million |
| Capital Expenditure | -3.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -5.1 Million | 698.98 Thousand | 1.07 Million | 2.4 Million | 344.82 Thousand | -2.36 Million |
| Free Cash Flow | -4.98 Million | -6.59 Million | -12.35 Million | -6.63 Million | -5.76 Million | -6.97 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.26 Million | -1.57 Million | -7.79 Million | -1.98 Million | -1.69 Million | -1.86 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 126.57 Thousand | 254.02 Thousand | 1.12 Million | 281.63 Thousand | 281.75 Thousand | 280.14 Thousand |
| Change in working capital | 195.36 Thousand | -1.37 Million | 1.55 Million | 586.28 Thousand | 331.07 Thousand | 342.84 Thousand |
| Other non-cash items | 515.69 Thousand | 920.86 Thousand | 129.07 Thousand | 13.37 Thousand | 39.47 Thousand | 38.55 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | -5.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 295.69 Thousand | 7.54 Million | -119.29 Thousand | -119.29 Thousand | - | - |
| Debt repayment | - | - | - | -115.7 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 3.26 Million | - | - | - | - | - |
| Common Stock Issuance | 295.69 Thousand | 7.54 Million | -119.29 Thousand | -119.29 Thousand | - | - |
| Other Financing Activities | 295.69 Thousand | -426.29 Thousand | -119.29 Thousand | -119.29 Thousand | - | - |
| Accounts receivables | -551.09 Thousand | -778.83 Thousand | -48.23 Thousand | 560.83 Thousand | -210.09 Thousand | -336.51 Thousand |
| Accounts payables | 242.62 Thousand | 343.59 Thousand | 655.12 Thousand | 191.99 Thousand | -17.86 Thousand | 229.38 Thousand |
| Inventory | 44.01 Thousand | -106.93 Thousand | -192.46 Thousand | -192.46 Thousand | 342.29 Thousand | 237.29 Thousand |
| Other working capital | 459.83 Thousand | -836.08 Thousand | 1.13 Million | 25.92 Thousand | 216.73 Thousand | 212.68 Thousand |
| Cash at beginning of period | 9.7 Million | 4.73 Million | 9.84 Million | 5.96 Million | 7 Million | 8.21 Million |
| Cash at end of period | 9.17 Million | 9.7 Million | 4.73 Million | 4.73 Million | 5.96 Million | 7 Million |
| Capital Expenditure | -5.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -524.91 Thousand | 4.96 Million | -5.1 Million | -1.22 Million | -1.04 Million | -1.2 Million |
| Free Cash Flow | -820.62 Thousand | -2.57 Million | -4.98 Million | -1.1 Million | -1.04 Million | -1.2 Million |
3910
3297
SMGBF
LGDDF
GASNF
0798